The liver as a crucial organ in the first line of host defense: the roles of Kupffer cells, natural killer (NK) cells and NK1.1 Ag+ T cells in T helper 1 immune responses.
The liver remains a hematopoietic organ after birth and can produce all leukocyte lineages from resident hematopoietic stem cells. Hepatocytes produce acute phase proteins and complement in bacterial infections. Liver Kupffer cells are activated by various bacterial stimuli, including bacterial lipopolysaccharide (LPS) and bacterial superantigens, and produce interleukin (IL)-12. IL-12 and other monokines (IL- 18 etc.) produced by Kupffer cells activate liver natural killer (NK) cells and NK1.1 Ag+ T cells to produce interferon-gamma and thereby acquire cytotoxicity against tumors and microbe-infected cells. These liver leukocytes and the T helper 1 immune responses induced by them thus play a crucial role in the first line of defense against bacterial infections and hematogenous tumor metastases. However, if this defense system is inadequately activated, shock associated with multiple organ failure takes place. Activated liver NK1.1 Ag+ T cells and NK cells also cause hepatocyte injury. NK1.1 Ag+ T cells and another T-cell subset with an intermediate T-cell receptor, CD 122+CD8+ T cells, can develop independently of thymic epithelial cells. Liver NK cells and NK1.1 Ag+ T cells physiologically develop in situ from their precursors, presumably due to bacterial antigens brought from the intestine via the portal vein. NK cells activated by bacterial superantigens or LPS are also probably involved in the vascular endothelial injury in Kawasaki disease.
Seki
S
S
Division of Basic Traumatology, National Defense Medical College Research Institute, Tokorozawa, Japan. btraums@ndmc.ac.jp
Habu
Y
Y
Kawamura
T
T
Takeda
K
K
Dobashi
H
H
Ohkawa
T
T
Hiraide
H
H
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D019070:Cell Lineage; D002675:Child, Preschool; D003208:Concanavalin A / Q000633:toxicity; D006094:Gram-Positive Bacteria / Q000276:immunology; D006801:Humans; D007408:Intestinal Absorption; D007694:Killer Cells, Natural / Q000276:immunology*; D007728:Kupffer Cells / Q000276:immunology* / Q000378:metabolism; D008070:Lipopolysaccharides / Q000276:immunology / Q000633:toxicity; D008099:Liver / Q000276:immunology*; D008102:Liver Circulation; D008213:Lymphocyte Activation; D008222:Lymphokines / Q000378:metabolism; D008262:Macrophage Activation; D051379:Mice; D016513:Mice, SCID; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology; D009102:Multiple Organ Failure / Q000209:etiology / Q000503:physiopathology; D009362:Neoplasm Metastasis; D009360:Neoplastic Cells, Circulating; D010538:Peritonitis / Q000150:complications / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000032:analysis; D012772:Shock, Septic / Q000150:complications / Q000276:immunology; D012790:Shwartzman Phenomenon / Q000276:immunology; D018089:Superantigens / Q000276:immunology; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism
D000942:Antigens, Bacterial; D008070:Lipopolysaccharides; D008222:Lymphokines; D011948:Receptors, Antigen, T-Cell; D016692:Receptors, Antigen, T-Cell, gamma-delta; D018089:Superantigens; D003208:Concanavalin A